期刊论文详细信息
Malaria Journal
A bioassay method validation framework for laboratory and semi-field tests used to evaluate vector control tools
Case Study
Angus Spiers1  Agnes Matope2  Geraldine M. Foster2  Rosemary S. Lees3 
[1] Innovation to Impact (I2I), Liverpool School of Tropical Medicine, Pembroke Place, L3 5QA, Liverpool, UK;Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, L3 5QA, Liverpool, UK;Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, L3 5QA, Liverpool, UK;Innovation to Impact (I2I), Liverpool School of Tropical Medicine, Pembroke Place, L3 5QA, Liverpool, UK;
关键词: Vector;    Bioassay;    Insecticide;    Evaluation;    Validation;    Verification;    Precision;    Variability;    Feasibility;    Insects;    ITN;    Control;   
DOI  :  10.1186/s12936-023-04717-w
 received in 2023-03-18, accepted in 2023-09-13,  发布年份 2023
来源: Springer
PDF
【 摘 要 】

Vector control interventions play a fundamental role in the control and elimination of vector-borne diseases. The evaluation of vector control products relies on bioassays, laboratory and semi-field tests using live insects to assess the product’s effectiveness. Bioassay method development requires a rigorous validation process to ensure that relevant methods are used to capture appropriate entomological endpoints which accurately and precisely describe likely efficacy against disease vectors as well as product characteristics within the manufacturing tolerance ranges for insecticide content specified by the World Health Organization. Currently, there are no standardized guidelines for bioassay method validation in vector control. This report presents a framework for bioassay validation that draws on accepted validation processes from the chemical and healthcare fields and which can be applied for evaluating bioassays and semi-field tests in vector control. The validation process has been categorized into four stages: preliminary development; feasibility experiments; internal validation, and external validation. A properly validated method combined with an appropriate experimental design and data analyses that account for both the variability of the method and the product is needed to generate reliable estimates of product efficacy to ensure that at-risk communities have timely access to safe and reliable vector control products.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 预 览 】
附件列表
Files Size Format View
RO202310110962115ZK.pdf 2543KB PDF download
MediaObjects/41408_2023_908_MOESM2_ESM.pdf 3090KB PDF download
MediaObjects/13046_2023_2830_MOESM2_ESM.docx 47KB Other download
13731_2023_332_Article_IEq6.gif 1KB Image download
Fig. 2 240KB Image download
42004_2023_990_Article_IEq38.gif 1KB Image download
40708_2023_202_Article_IEq25.gif 1KB Image download
【 图 表 】

40708_2023_202_Article_IEq25.gif

42004_2023_990_Article_IEq38.gif

Fig. 2

13731_2023_332_Article_IEq6.gif

【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  • [50]
  • [51]
  • [52]
  • [53]
  • [54]
  • [55]
  • [56]
  • [57]
  • [58]
  • [59]
  • [60]
  • [61]
  • [62]
  • [63]
  • [64]
  • [65]
  • [66]
  • [67]
  • [68]
  • [69]
  • [70]
  • [71]
  • [72]
  • [73]
  • [74]
  • [75]
  • [76]
  • [77]
  • [78]
  • [79]
  • [80]
  • [81]
  • [82]
  • [83]
  • [84]
  • [85]
  • [86]
  • [87]
  • [88]
  • [89]
  • [90]
  文献评价指标  
  下载次数:10次 浏览次数:5次